Abstract
ABSTRACT: In a small‐scale preliminary trial of oral rifampicin treatment was considered successful in six out of eight cutaneous leishmaniasis patients and probably effective in a seventh. The in vitro effect of rifampicin on leishmania organisms concerns inhibition of mitochondrial function or replication. The need for protozoological control in the assessment of treatment is stressed.
Original language | English |
---|---|
Pages (from-to) | 110-112 |
Number of pages | 3 |
Journal | International Journal of Dermatology |
Volume | 21 |
Issue number | 2 |
DOIs | |
State | Published - 1 Jan 1982 |
Externally published | Yes |
ASJC Scopus subject areas
- Dermatology